Knowledge Base (107)
ERS 2017 COPD congress report
Summary of the latest data on COPD developments from the 2017 ERS congress in Milan, Italy
Improving inhaler use through optimising adherence and training
Experts discuss the importance of correct inhaler technique in improving treatment adherence.
ERS 2017 Webinar: Environmental influences
Richard Russell and Thérèse Lapperre discuss environmental influences in COPD
ERS 2017 Webinar: Pathophysiology
Richard Russell and Thérèse Lapperre discuss the pathophysiology of COPD
ERS 2017 Webinar: Diagnosis & assessment
COPD experts discuss diagnosis & assessment data to come out of the ERS 2017 congress
ERS 2017 Webinar: Characterisation & precision medicine
Richard Russell, Salman Siddiqui, and Thérèse Lapperre discuss phenotyping, biomarkers and endotyping
ERS 2017 Webinar: Imaging
Thérèse Lapperre and Salman Siddiqui provide insights in COPD imaging
ERS 2017 Webinar: Exacerbations
Richard Russell and Salman Siddiqui discuss exacerbations in COPD
ERS 2017 Webinar: Pharmacological treatment
Richard Russell and Salman Siddiqui discuss pharmacological treatment data from the ERS
ERS 2017 Webinar: Novel therapeutic approaches
Richard Russell and Salman Siddiqui discuss new treatments in COPD
ERS 2017 Webinar: Inhalers
A short update from the 2017 ERS congress about correct inhaler use in COPD.
ERS 2017 Webinar: Non-invasive ventilation
Richard Russell and Thérèse Lapperre discuss non-invasive ventilation for COPD
ERS 2017 Webinar: Care in advanced COPD
Richard Russell and Salman Siddiqui discuss care in advanced COPD
ERS 2017 Webinar: Smoking cessation & eCigarettes
Richard Russell and Thérèse Lapperre discuss smoking cessation & eCigarettes.
ERS 2017 Webinar: Comorbidities in COPD
Richard Russell, Thérèse Lapperre and Salman Siddiqui discuss comorbidities in COPD
ERS 2017 Webinar: Cardio-respiratory crosstalk
The experts discuss a new concept at the 2017 ERS: Cardio-respiratory crosstalk.
ATS 2017: Making inroads towards personalised medicine: phenotyping
The experts discuss COPD phenotyping as a means to personalised treatment.
ATS 2017: LAMA/LABA combinations
COPD experts discuss LAMA/LABA therapy and outcomes with respect to ICS withdrawal.
ATS 2017: Oxygen therapy and mechanical ventilation in COPD
COPD experts discuss recent data on LTOT and mechanical ventilation.
ATS 2017: Public health concerns & strategies in COPD
Environmental exposure and lung function, new screening recommendations, and more.
ATS 2017: Non-pharmacological treatment for COPD
The importance of pulmonary rehabilitation and digital technologies/telehealth in COPD.
ATS 2017: Comorbidities in COPD
The experts discuss the need for a holistic approach to treating COPD.
ATS 2017: Diagnosis & assessment of COPD
Experts discuss the new GOLD guidelines, developments in imaging, and gender differences.
ATS 2017: Role of ICS, triple therapy, and roflumilast in COPD
COPD experts discuss the use of ICS, triple therapy (LAMA/LABA/ICS) and roflumilast.
ATS 2017: eCigarettes & smoking cessation
COPD experts discuss eCigarette use, and the importance of smoking cessation.
ATS 2017: Pathophysiology of COPD
Dr Richard Russell and Dr Frits Franssen discuss the early stages of COPD progression.
ATS 2017: Early COPD and smokers with preserved lung function
The experts discuss early detection of COPD and smokers with preserved lung function.
ATS 2017: Exacerbations in COPD
The experts discuss the prediction and prevention of exacerbations.
Introduction to the ATS 2017 COPD webinar series
2017 ATS webinar series with Dr Richard Russell, Prof Michael Dreher and Dr Frits Franssen
ATS 2017: Making inroads towards personalised medicine: eosinophils
The experts discuss the use of eosinophils as a potential biomarker for COPD.